Karuna Therapeutics Total Revenue

Karuna Therapeutics (KRTX) currently reports a total revenue of $650K as of December 2023. That compares with $11M in the prior-year period — down 93.9% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Karuna Therapeutics's total revenue history and peer comparisons.

Karuna Therapeutics's total revenue decreased from $11M to $650K — a 93.9% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Karuna Therapeutics's total revenue of $650K is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Karuna Therapeutics reported $650K in total revenue as of December 2023. That compares with $11M in the prior-year period — down 93.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $650K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Karuna Therapeutics, and consider following KRTX for alerts when major investors trade the stock.